BioSpace News Archive

Value Partnership builds on the long-standing relationship between Siemens Healthineers and WakeMed Health & Hospitals

MedPharm Holdings, a leading medical cannabis manufacturer, R&D laboratory, and compounding facility, announced today they will not be extending their term sheet for acquisition with Schwazze, Inc. (SHWZ), formerly operating as Medicine Man Technologies. The term sheet expires today, September 30, 2020. “After more than a year and a half of negotiations we have mutually agreed with Schwazze, this transaction no longer s

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the addition of Nils Lonberg , Ph.D., to its Scientific Advisory Board (SAB). Dr. Lonberg is a pioneer in the field of immuno-oncology and has more than 30 years of experience in the biopha

Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer ® and pre|CISION™ platforms, is pleased to announce that the BAMS™ assay to detect the SARS-CoV-2 virus has been launched as a research kit 1 by its partner Adeptrix (Beverly, M

Project: AI based Assay Development for carbapenem-resistance based on porin loss and efflux pump overexpression in G ram-negative bacteria Project is part of the Research Campus Infecto G nostics and includes project partners at the University Hospital Jena, Institute for Infectious Diseases and Infection Contro l GAITHERSBURG, Md., and HOLZGERLINGEN, Germany, Sept. 30, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the pow

Healthcare providers across the United States can now access three different test options from Quest Diagnostics (NYSE: DGX) to aid the diagnosis of COVID-19 and differentiate it from o

iScience review paper details use of amino acids in medicine Axcella focused on designing novel EMM compositions with the potential to tackle complex diseases; plans to advance lead candidates into later-stage clinical trials CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) com

BIONIK Laboratories Announces Sale of New InMotion ® ARM/HAND Robotic Device to VA Rehabilitation Research & Development’s Center for Neurorestoration and Neurotechnology VA-funded center purchases second InMotion ® ARM/HAND interactive therapy system to test new approaches for restoring physical function of veterans with neurologic disease or injury TORONTO & BOSTON--( BUSINESS WIRE )-- BIONIK Laboratories Corp . (OTCQB:BNKL) (“BIONIK” or

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced two poster presentations as part of the World Muscle Society (WMS) 2020 Virtual Congress. The SRK-015 clinical development poster will showcase previously presented data from the Phase 1 healthy volunteer trial, as well as baselin

The new cardiac Hybrid OR at London Health Sciences Centre (LHSC) in London, Ontario represents a new frontier in cardiac surgery. The customized operating room (OR) features a 3-D imaging system with an integrated OR table that together improve workflow, increase efficiency and ensure a high-level of infection control.